Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
about
Targeting heart failure with preserved ejection fraction: current status and future prospectsHow to diagnose heart failure with preserved ejection fraction: the value of invasive stress testingUnderstanding heart failure with preserved ejection fraction: where are we today?Reporting trends of randomised controlled trials in heart failure with preserved ejection fraction: a systematic reviewInequity of access to ACE inhibitors in Swedish heart failure patients: a register-based studyHeart failure as a general pandemic in AsiaHeart failure with preserved ejection fraction: mechanisms, clinical features, and therapiesCardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunctionPatient selection in heart failure with preserved ejection fraction clinical trialsHeart failure with preserved ejection fractionThe cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionAddressing the Heterogeneity of Heart Failure in Future Randomized Trials.Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationA 70-year-old woman with heart failure with preserved ejection fraction.Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions.Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.Developing therapies for heart failure with preserved ejection fraction: current state and future directionsIncidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).Diastolic dysfunction and cardiac troponin I decrease in aging hearts.Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunctionDesigning effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.Long-term survival for patients with acute decompensated heart failure according to ejection fraction findingsA pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis?Noncardiac comorbidities in heart failure with reduced versus preserved ejection fractionEffects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials.The E-wave deceleration rate E/DT outperforms the tissue Doppler-derived index E/e' in characterizing lung remodeling in heart failure with preserved ejection fraction.Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessonsTowards 'Eternal Youth' of cardiac and skeletal muscle.Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study.EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4What Is the Evidence That the Tissue Doppler Index E/e' Reflects Left Ventricular Filling Pressure Changes After Exercise or Pharmacological Intervention for Evaluating Diastolic Function? A Systematic Review.Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders.Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction.Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]).Magnitude of and Prognostic Factors Associated With 1-Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction FindingsEpidemiology and aetiology of heart failure.Heart failure in North America.
P2860
Q26752956-D599A276-1AA5-4675-B6F4-B7B626B169ADQ26766355-B9E297CD-0501-4058-89C9-DC0EE1769E66Q26766590-8A3400EC-D164-44A0-8B4D-D4860824D7DAQ26779538-F58E115A-F5F0-4C76-BCE6-60D14B7BE1E8Q26799578-75A6861B-7DB9-4296-9CCF-329C9D705210Q26801810-E395379E-AA7B-40E5-89DD-507B47F0662DQ27000263-B61672E5-4748-4432-AE10-ADA377A7978DQ27002918-C776152A-35CF-4365-87A7-1248A7C6420BQ27015845-201C8ACB-2342-4A0C-B700-A299AEE1555AQ27024008-ABD55E05-F7BF-4B17-A45E-E931714B3F31Q27024279-30D63BCE-F8B2-4574-BF27-DD704483300EQ30234708-73D6C4EC-7B7A-425C-88D3-21498EB5F66BQ30238784-BEDE082F-B1C0-474C-920C-4CD04AD8737EQ30359520-081CABA9-0C72-4A55-85C8-77244A48438DQ31159585-BDA66DDA-20E7-43E6-A771-2F921ED6187EQ33164540-895ED719-95A6-455D-9E43-087D1BA2BDBEQ33639223-50F29AAD-34F4-42D8-8D9E-E00459E867ACQ33685255-84FF2072-01DC-4444-8D69-8CBD7E9C7FFAQ33739058-5293EDA0-F62C-43C8-980E-BE868914AC07Q33877795-AF608C65-2BCF-4FBE-BA28-71C7BDFC5562Q34162294-2C5EF475-29D0-4BFB-9248-C6F38E7E38B0Q34173702-F3054CBE-F37F-4D00-8943-3B9E784E2CB5Q34473637-5A11E20D-89A7-4AAD-A896-F65F7C33DC52Q34625223-81167A23-9F28-4988-AA9F-DDD7031FED5AQ35018046-9AE1DBA0-FE96-480A-BCEC-EA7AEB563D86Q35061446-1F73680F-5058-45A7-9A5A-8700BABBA15FQ35139959-6889DCA2-BEF5-4870-8E69-76A9374611A6Q35662642-8DA44230-18A9-40D0-88D4-4BC8658C8345Q36266675-DCBE2B5F-2EC9-48FA-8DDD-21E95249E5AEQ36288050-E13E9A61-6E8F-4399-B916-0CD9F638E04CQ36307290-C73E65F9-31D6-4397-8D20-BE2A0BF259C0Q36309692-016CD488-B417-4505-A6B1-B83E99675CD7Q36361518-B9F53318-E936-46E2-BBE0-A183A460B376Q36410248-901639BA-C9D0-4F71-9746-DAB57116E2A5Q36683918-3A34061D-6BA7-4F74-BA2E-C55DAA1B1D26Q36784075-13C0896F-E682-4F0C-9C20-AEB319AF7004Q36807898-1D9B910B-CFAF-4973-BCAB-00723C6417CEQ36836423-DF712BF2-FF4F-48EF-8A24-DFF106804B45Q36905978-CB738B28-1C32-43A9-BD86-05A3F34F047AQ36928519-4577A713-60DE-49DE-A373-2DACD57927C7
P2860
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Trends in patients hospitalize ...... ence, therapies, and outcomes.
@en
Trends in patients hospitalize ...... ence, therapies, and outcomes.
@nl
type
label
Trends in patients hospitalize ...... ence, therapies, and outcomes.
@en
Trends in patients hospitalize ...... ence, therapies, and outcomes.
@nl
prefLabel
Trends in patients hospitalize ...... ence, therapies, and outcomes.
@en
Trends in patients hospitalize ...... ence, therapies, and outcomes.
@nl
P2093
P50
P921
P1433
P1476
Trends in patients hospitalize ...... ence, therapies, and outcomes.
@en
P2093
Benjamin A Steinberg
Christopher P Cannon
Deepak L Bhatt
Get With the Guidelines Scientific Advisory Committee and Investigators
P356
10.1161/CIRCULATIONAHA.111.080770
P407
P577
2012-05-21T00:00:00Z